Effect of HLA Class II Gene Disparity on Clinical Outcome in Unrelated Donor Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia: The US National Marrow Donor Program Experience

Blood - United States
doi 10.1182/blood.v98.10.2922
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Unrelated Donor Marrow Transplantation for Acute Myeloid Leukemia: An Update of the Seattle Experience

Bone Marrow Transplantation
TransplantationHematology
2000English

Unrelated Donor Marrow Transplantation for Myelodysplastic Syndromes: Outcome Analysis in 510 Transplants Facilitated by the National Marrow Donor Program

Blood
BiochemistryImmunologyCell BiologyHematology
2002English

The Impact of Donor KIR and Patient HLA-C Genotypes on Outcome Following HLA-identical Sibling Hematopoietic Stem Cell Transplantation for Myeloid Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

Outcomes From Unrelated Donor Hematopoietic Stem Cell Transplantation

Cancer Control
MedicineOncologyHematology
2011English

National Marrow Donor Program

2008English

National Marrow Donor Program

2011English

Impact of the Donor KIR Genotype on the Clinical Outcome of Hematopoietic Stem Cell Unrelated Transplants: A Single Center Experience

2018English

Donor-Derived Myeloid Neoplasm Post Allogeneic Hematopoietic Cell Transplantation

Blood
BiochemistryImmunologyCell BiologyHematology
2017English

HLA-DPA1 Mismatch Is Associated With Decreased Overall Survival Following Unrelated Donor Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy